Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurocrine (DE:NB3)
FRANKFURT:NB3
Neurocrine (NB3) Ownership - Who Owns Neurocrine?
0 Followers
Neurocrine (NB3) Ownership Overview
16.31% Insiders
25.80% Mutual Funds
26.23% Other Institutional Investors
31.66% Public Companies and
Individual Investors
The ownership structure of Neurocrine (DE:NB3) stock is a mix of institutional, retail and individual investors. Approximately 52.03% of the company’s stock is owned by Institutional Investors, 16.31% is owned by Insiders and 31.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 14, 2024 | Kevin Charles Gorman Ceo,director | Bought | $199951 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $1185 | |
| Dec 31, 2023 | Bought | $38605 | |
| Dec 31, 2023 | Bought | $221488 | |
| Dec 31, 2023 | Bought | $729686 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,814,555 | Institution | 10.87% | 1,428,581,086 | |
| 9,264,715 | Institution | 9.31% | 1,223,850,322 | |
| 8,456,880 | Institution | 8.50% | 1,117,136,934 | |
| 2,065,931 | Institution | 2.08% | 272,905,353 | |
| 1,259,744 | Institution | 1.27% | 166,409,663 | |
| 984,993 | Institution | 0.99% | 130,115,605 | |
| 953,926 | Institution | 0.96% | 126,011,717 | |
| 930,411 | Institution | 0.94% | 122,905,432 | |
| 896,719 | Institution | 0.90% | 118,454,786 | |
| 786,542 | Institution | 0.79% | 103,900,625 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,456,880 | Institution | 8.50% | 1,117,136,934 | |
| 984,993 | Institution | 0.99% | 130,115,605 | |
| 953,926 | Institution | 0.96% | 126,011,717 | |
| 930,411 | Institution | 0.94% | 122,905,432 | |
| 786,542 | Institution | 0.79% | 103,900,625 | |
| 656,222 | Institution | 0.66% | 86,685,614 | |
| 646,935 | Institution | 0.65% | 85,458,820 | |
| 599,176 | Institution | 0.60% | 79,149,951 | |
| 534,113 | Institution | 0.54% | 70,555,259 | |
| 512,523 | Institution | 0.52% | 67,703,263 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Neurocrine (DE:NB3)?
According to the latest TipRanks data, approximately 26.23% of the company's stock is held by institutional investors, 16.31% is held by insiders, and 31.66% is held by retail investors.
What percentage of Neurocrine (DE:NB3) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.23% of Neurocrine (DE:NB3) stock is held by institutional investors.
What percentage of Neurocrine (DE:NB3) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.66% of Neurocrine (DE:NB3) stock is held by retail investors.
Who owns the most shares of Neurocrine (DE:NB3)?
iShares owns the most shares of Neurocrine (DE:NB3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.